WisPaper
WisPaper
Search
Assistant
Pricing
TrueCite

Does the gut-brain axis influence mental health?

Yes, the gut-brain axis influences mental health. Gut microbes affect mood and brain function via immune, neural, and metabolic pathways.

Direct answer

Yes, the gut-brain axis clearly influences mental health. The gut microbiome communicates with the brain through immune signals, nerve pathways (like the vagus nerve), and bacterial metabolites, and imbalances in gut bacteria are linked to conditions like depression, anxiety, schizophrenia, and ADHD. For example, a large 2025 Mendelian randomization study found causal links between specific gut bacteria and six major psychiatric disorders, with inflammatory factors acting as mediators [1]. Across the studies reviewed here, the strongest evidence comes from large-scale genetic analyses and systematic reviews that consistently show gut microbiome alterations in people with psychiatric disorders, though most studies note that more rigorous clinical trials are needed to confirm cause-and-effect and to develop reliable treatments [2][5][11].

14sources cited

This article was generated with WisPaper-powered search and paper analysis.

How does the gut actually talk to the brain?

The gut and brain are connected by a two-way communication system called the gut-brain axis. This isn't just a metaphor — it's a physical and chemical link that includes the vagus nerve (a major nerve running from the brainstem to the abdomen), immune system signals, hormones, and the metabolites produced by gut bacteria [8][9]. Your gut microbes can produce or influence neurotransmitters like serotonin and GABA, which directly affect mood and cognition [12]. One review describes this as a 'diet-microbiota-gut-brain axis,' emphasizing that what you eat changes your gut bacteria, which in turn changes how your brain works [2].

The immune system is a key player here. A 2025 Mendelian randomization study — a method that uses genetic data to infer cause-and-effect — found that inflammatory factors like MCSF, GDNF, and CD40 act as mediators between specific gut bacteria and psychiatric disorders. For instance, the link between the gut bacterium Roseburia and ADHD was partly explained by the inflammatory factor MCSF, accounting for about 3.3% of the effect [1]. Another large genetic study of over 53,000 people with irritable bowel syndrome (IBS) found extensive shared genetic overlap between IBS and psychiatric disorders, with shared genes enriched in nervous and immune system pathways, further supporting this gut-brain-immune connection [3].

Does changing your gut bacteria actually improve mental health?

The evidence is promising but mixed. On the one hand, large-scale genetic studies provide strong support for a causal role. The 2025 Mendelian randomization study found significant causal relationships between 11 gut bacteria and ADHD, 11 and bipolar disorder, 15 and schizophrenia, and 5 and autism spectrum disorder [1]. A 2023 genome-wide pleiotropic association study (which looks at shared genetic variants across conditions) identified 83 shared genetic loci between gastrointestinal diseases and psychiatric disorders, many of which also overlapped with genes that influence gut microbiome composition [10]. These findings suggest that the link is not just correlation — there is a biological, genetic basis.

On the other hand, when it comes to actually treating mental health by changing the microbiome — for example, with probiotics or diet — the results are more modest. A 2021 meta-analysis of 23 clinical trials found that probiotics significantly reduced depressive symptoms (standardized mean difference = -0.87, a large effect), but had no significant effect on anxiety or schizophrenia symptoms [7]. More recent reviews echo this: dietary changes (like high-fiber or fermented foods) show benefit in mild anxiety and depression, but the evidence for supplements and probiotics is conflicting [5]. A 2024 review notes that fermented foods, which contain live microbes and beneficial metabolites, are a promising whole-food approach, but human studies are still limited and face challenges like variability in study design [4].

Importantly, the strongest evidence for a gut-brain effect comes from studies that look at the whole system — genetics, inflammation, and microbiome together — rather than any single intervention. A 2024 review of the gut-brain-immune axis concludes that dysbiosis (microbial imbalance) and inflammation are consistently linked to stress, depression, autism, and schizophrenia, and that restoring microbial balance with probiotics, prebiotics, and diet shows promise, but calls for more personalized treatments [14].

What are the limitations of this research?

Despite the excitement, there are important caveats. First, many studies are observational or rely on genetic correlations, which don't prove that changing the microbiome will reliably improve symptoms in a given person. The 2025 Mendelian randomization study, while rigorous, is based on genetic data and doesn't test actual interventions [1]. Second, clinical trial results are inconsistent. The 2021 meta-analysis found probiotics helped depression but not anxiety or schizophrenia, and the authors noted high variability between studies [7]. A 2025 systematic review of 80 studies found consistent patterns of gut microbiome disruption across psychiatric disorders, but emphasized that most studies were small and used different methods, making it hard to draw firm conclusions [13].

Another limitation is that the gut microbiome is highly individual — influenced by diet, stress, medications, and even birth method [9]. What works for one person may not work for another. A 2024 review on the gut-brain axis in mental health notes that while probiotics containing Lactobacillus and Bifidobacterium show the most benefit, these bacteria don't permanently colonize the gut, so effects may not last [8]. Finally, most research has focused on depression and anxiety, with less data on conditions like bipolar disorder or schizophrenia [6][11]. The authors of a 2025 narrative review conclude that while the gut-brain axis is a promising target, stronger, multicenter randomized controlled trials with standardized methods are needed before these findings can be translated into routine clinical practice [11].

About These Sources

This answer is built on 14 peer-reviewed studies — published from 2021 to 2026, 10 from 2024 or later, 6 in Q1 journals, collectively cited 1,012 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 56 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Targeting the gut microbiota-inflammation-brain axis as a potential therapeutic strategy for psychiatric disorders: A Mendelian randomization analysis.

Using Mendelian randomization (a genetic method to infer causality) on large GWAS datasets, this 2025 study found significant causal links between specific gut bacteria and six psychiatric disorders (ADHD, anxiety, bipolar, anorexia, schizophrenia, autism), with inflammatory factors like MCSF, GDNF, and CD40 acting as partial mediators (e.g., 3.3% of the Roseburia-ADHD link was mediated by MCSF).

2

Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis

This 2024 Nature Metabolism review proposes a 'diet-microbiota-gut-brain axis,' arguing that diet robustly shapes gut microbiota composition and function, which in turn affects cognition and emotional functioning, and that this axis is a tractable target for brain health.

3

Shared genetic architecture between irritable bowel syndrome and psychiatric disorders reveals molecular pathways of the gut-brain axis

A 2023 genome-wide study of 53,400 IBS cases and 433,201 controls found extensive polygenic overlap between IBS and psychiatric disorders, identifying 70 shared genetic loci enriched in nervous and immune system pathways, supporting a shared genetic basis for gut-brain axis conditions.

4

Fermented foods: Harnessing their potential to modulate the microbiota-gut-brain axis for mental health

This 2024 review highlights fermented foods as a combined whole-food and microbiota-modulating intervention that can target the microbiota-gut-brain axis, but notes significant knowledge gaps and challenges in designing human studies to prove mental health benefits.

5

Food and Mood: Current Evidence on Mental Health and the Microbiota-Gut-Brain Axis.

A 2025 review of diet and mood finds that while mostly observational, mounting data from RCTs support that dietary modification (high-fiber, fermented, ketogenic diets) can improve mental health by altering gut microbes, but evidence for supplements and probiotics is conflicting.

6

Mind, Mood and Microbiota—Gut–Brain Axis in Psychiatric Disorders

This 2024 review emphasizes that gut microbiota alterations influence brain processes via the brain-gut axis, and that probiotic/prebiotic supplements may alleviate psychiatric symptoms like those in depression, anxiety, and schizophrenia, while psychotropic drugs also affect microbiome diversity.

7

From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders.

A 2021 meta-analysis of 23 clinical trials found that probiotics significantly reduced depressive symptoms (SMD = -0.87) but had no significant effect on anxiety or schizophrenia symptoms, highlighting mixed evidence for probiotic efficacy in psychiatric disorders.

8

Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders

A 2024 review of the gut-brain axis in mental health notes that probiotics (especially Lactobacillus and Bifidobacterium) show benefit for mental health symptoms, but these bacteria do not permanently colonize the gut, and the vagus nerve is a key but understudied communication pathway.

9

The Microbiota–Gut–Brain Axis in Psychiatric Disorders

This 2022 review discusses the link between gut microbiome and psychiatric disorders (MDD, schizophrenia, bipolar, ASD, ADHD) via multiple pathways (neurotransmitters, immune, endocrine, metabolites), emphasizing factors like stress, diet, and circadian rhythm.

10

Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders

A 2023 genome-wide pleiotropic association study of 4 gastrointestinal diseases and 6 psychiatric disorders found 83 shared genetic loci and 158 shared genes, enriched in cell adhesion, synaptic, and immune pathways, with several loci also linked to gut microbiome composition.

11

THE ROLE OF GUT BRAIN AXIS IN PSYCHIATRIC DISORDERS NARRATIVE REVIEW

This 2025 narrative review concludes that microbiota-gut-brain interactions contribute to depression and anxiety pathophysiology, but stronger, multicenter RCTs with standardized methods are required before clinical integration.

12

Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review.

A 2024 comprehensive review explains that gut microbiota influence mental health through neurotransmitter production, neuroinflammation, and gut barrier integrity, and that dysbiosis is associated with increased susceptibility to psychiatric illnesses.

13

Microbial dysbiosis as a diagnostic marker in psychiatric disorders: a systematic review of gut-brain axis disruptions.

A 2026 systematic review of 80 studies found consistent patterns of gut microbial dysbiosis (e.g., reduced diversity, altered Firmicutes/Bacteroidetes ratio) across psychiatric disorders, suggesting potential microbial biomarkers, but calls for longitudinal studies with standardized methods.

14

Gut-brain-immune axis implications for mental health and disease.

This 2025 review of the gut-brain-immune axis concludes that dysbiosis and inflammation are linked to stress, depression, autism, and schizophrenia, and that therapeutic approaches (probiotics, prebiotics, diet) show promise but require more research on mechanisms and personalized treatments.